نتایج جستجو برای: oral etoposide

تعداد نتایج: 265365  

2015
Dongmei Sun Haibao Peng Shilong Wang Dazhang Zhu

Nanobelt carriers have demonstrated some advantages such as good biocompatibility, biodegradability, and strain-accommodating properties. We prepared an optimized nanobelt carrier formulation for drug (etoposide) as an oral delivery system and estimated the potential of calcium carbonate (CaCO3) nanobelts. The nanobelts were prepared by the method of binary solvent approach and were characteriz...

Journal: :Pediatric blood & cancer 2012
Andreas Peyrl Monika Chocholous Mark W Kieran Amedeo A Azizi Christina Prucker Thomas Czech Karin Dieckmann Maria-Theresa Schmook Christine Haberler Ulrike Leiss Irene Slavc

BACKGROUND Median survival time of recurrent embryonal brain tumors is short regardless of salvage chemotherapy used. An evolving alternative approach to conventional chemotherapy is to target neovascularization by interfering with tumor angiogenesis at various levels. PROCEDURE From November 2006 to December 2010, 16 patients (median age: 9 years) with recurrent (9 first, 7 multiple) embryon...

Journal: :The Journal of clinical investigation 2000
J Wijnholds E C deLange G L Scheffer D J van den Berg C A Mol M van der Valk A H Schinkel R J Scheper D D Breimer P Borst

Multidrug resistance protein 1 (MRP1) is a transporter protein that helps to protect normal cells and tumor cells against the influx of certain xenobiotics. We previously showed that Mrp1 protects against cytotoxic drugs at the testis-blood barrier, the oral epithelium, and the kidney urinary collecting duct tubules. Here, we generated Mrp1/Mdr1a/Mdr1b triple-knockout (TKO) mice, and used them ...

A series of 2-amino-4-(nitroalkyl)-4H-chromene-3-carbonitriles were synthesized by an efficient multicomponent reaction in aqueous media using DBU (1,8-diazabicyclo[5.4.0]undec-7-ene) as a catalyst at room temperature. Mild condition, environment friendly procedure and excellent yields are the main advantages of this procedure. The cytotoxic activity of target compounds were evaluated against t...

Journal: :Oncology reports 2012
Lahcen Eddabra Thomas Wenner Hassan El Btaouri Thomas Baranek Claudie Madoulet Pascale Cornillet-Lefebvre Hamid Morjani

Resistance to etoposide has been associated with the overexpression of P-glycoprotein and MRP1 in human tumor cells. However, the role of BCRP in resistance to etoposide has not been clearly established, especially the significance of arginine 482 mutations in drug transport (cellular uptake and efflux). Different levels of resistance to etoposide...

Journal: :Molecular pharmacology 1999
V E Kagan J C Yalowich G G Borisenko Y Y Tyurina V A Tyurin P Thampatty J P Fabisiak

Etoposide (VP-16) is extensively used to treat cancer, yet its efficacy is calamitously associated with an increased risk of secondary acute myelogenous leukemia. The mechanisms for the extremely high susceptibility of myeloid stem cells to the leukemogenic effects of etoposide have not been elucidated. We propose a mechanism to account for the etoposide-induced secondary acute myelogenous leuk...

Journal: :Blood 2002
Wyndham H Wilson Michael L Grossbard Stefania Pittaluga Diane Cole Deborah Pearson Nicole Drbohlav Seth M Steinberg Richard F Little John Janik Martin Gutierrez Mark Raffeld Louis Staudt Bruce D Cheson Dan L Longo Nancy Harris Elaine S Jaffe Bruce A Chabner Robert Wittes Frank Balis

We hypothesized that incremental improvements in the cyclophosphamide-doxorubicin-vincristine-prednisone (CHOP) chemotherapy regimen through optimization of drug selection, schedule, and pharmacokinetics would improve outcome in patients with large B-cell lymphomas. A prospective multi-institutional study of administration of etoposide, vincristine, and doxorubicin for 96 hours with bolus doses...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید